Document is current
Any future updates will be listed below
-
Authors
Beach, Catherine Z.
Febres-Aldana, Christopher A.
Marti, Juan Luis Gomez
Asiry, Saeed
Wong, Tamika
Boockvar, John A.
D’Amico, Randy S.
Somwar, Romel
Davare, Monika A.
Vojnic, Morana
-
Funding
Funding for this research was provided by:
Friends of Doernbecher grant
National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 4 April 2025
Accepted: 2 August 2025
First Online: 16 August 2025
Competing interests
: Dr. Vojnic reports consulting/advisory boards: Astrazeneca, Bristol-Meyers Squibb, I3 Health, MJH Lifesciences, IDEOLogy Health. Romel Somwar has received research grant support from Elevation Oncology, Loxo Oncology, Merus and Helsinn Healthcare, all unrelated to the current manuscript. The remaining authors declare no competing interests.
